Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Care experiences of Hereditary Cancer Syndrome (HCS) patients who have received a positive genetic test result for Hereditary Breast and Ovarian Cancer syndrome (HBOC) or Lynch Syndrome (LS) across 3 provinces in Canada
FY 2022-23
Summary
Hereditary cancer syndromes (HCS) account for 5-10% of all cancers and occur when a person has a genetic mutation that puts them at increased risk of developing certain cancers. The most common HCSs are hereditary breast and ovarian cancer syndrome (HBOC), caused by pathogenic variants in BRCA1/2 genes and Lynch Syndrome (LS). Both HBOC and LS can increase ones’ risk for cancers by over 80% during their lifetime. HCS patients require lifelong follow-up care as they are at risk of developing cancers at a younger age, making their preventative care and screening of critical importance. However, after getting a positive HCS test result, patients are often left on their own to navigate a complex, fragmented system of care where risk recommendations and surveillance guidelines are variable. The aim of this study is to understand the care experiences of HCS patients who received a positive genetic test result for HBOC or Lynch Syndrome in Ontario (ON), Newfoundland (NL), and British Columbia (BC). Care impacts will be generally defined as experiences of HCS-positive patients receiving medical care related to their cancer risk diagnosis (e.g., coordination of care, knowledge of providers, challenges with the healthcare system, and screening). This study will use qualitative methodology and due to its aim of informing clinical practice, analysis will draw on interpretive description. Semi-structured interviews will be conducted among a purposive sample of HCS patients from ON, NL, and BC. Data collection and analysis will occur simultaneously and iteratively. This study will elucidate the first insights of care experiences and needs of this population to co-design a more coordinated, patient-centred care, optimizing care experiences and ultimately patient outcomes.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
486646
Name
Butkowsky Carly
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Care experiences of Hereditary Cancer Syndrome (HCS) patients who have received a positive genetic test result for Hereditary Breast and Ovarian Cancer syndrome (HBOC) or Lynch Syndrome (LS) across 3 provinces in Canada
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer; Care; Coordination; Genetic Counselling; Genetics; Hereditary Cancer Syndromes; Interviews; Policy; Qualitative; Qualitative Methods
Abstract
Hereditary cancer syndromes (HCS) account for 5-10% of all cancers and occur when a person has a genetic mutation that puts them at increased risk of developing certain cancers. The most common HCSs are hereditary breast and ovarian cancer syndrome (HBOC), caused by pathogenic variants in BRCA1/2 genes and Lynch Syndrome (LS). Both HBOC and LS can increase ones’ risk for cancers by over 80% during their lifetime. HCS patients require lifelong follow-up care as they are at risk of developing cancers at a younger age, making their preventative care and screening of critical importance. However, after getting a positive HCS test result, patients are often left on their own to navigate a complex, fragmented system of care where risk recommendations and surveillance guidelines are variable. The aim of this study is to understand the care experiences of HCS patients who received a positive genetic test result for HBOC or Lynch Syndrome in Ontario (ON), Newfoundland (NL), and British Columbia (BC). Care impacts will be generally defined as experiences of HCS-positive patients receiving medical care related to their cancer risk diagnosis (e.g., coordination of care, knowledge of providers, challenges with the healthcare system, and screening). This study will use qualitative methodology and due to its aim of informing clinical practice, analysis will draw on interpretive description. Semi-structured interviews will be conducted among a purposive sample of HCS patients from ON, NL, and BC. Data collection and analysis will occur simultaneously and iteratively. This study will elucidate the first insights of care experiences and needs of this population to co-design a more coordinated, patient-centred care, optimizing care experiences and ultimately patient outcomes.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Butkowsky, Carly
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~